NasdaqGM - Nasdaq Real Time Price USD
Protara Therapeutics, Inc. (TARA)
4.2200
+0.0200
+(0.48%)
As of 9:54:04 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 172,500 | 5 |
| Sales | 21,224 | 1 |
| Net Shares Purchased (Sold) | 151,276 | 6 |
| Total Insider Shares Held | 1.32M | -- |
| % Net Shares Purchased (Sold) | 12.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ZUMMO JACQUELINE Officer | Sale at price 4.53 per share. | Direct | 96,145 | Mar 26, 2025 |
| ZUMMO JACQUELINE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| FRY HANNAH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| FABBIO PATRICK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| SHEFFERMAN JESSE M Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.71 per share. | Indirect | 271,715 | Sep 12, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.77 - 1.89 per share. | Indirect | 114,251 | Sep 10, 2024 |
| SHEFFERMAN JESSE M Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 28, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.44 per share. | Indirect | 27,828 | Jul 16, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.21 - 2.40 per share. | Indirect | 175,842 | Jul 11, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.12 per share. | Indirect | 17,598 | Jul 1, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.07 - 2.26 per share. | Indirect | 142,503 | Jun 28, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.26 per share. | Indirect | 28,734 | Jun 25, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.90 - 2.94 per share. | Indirect | 44,008 | May 31, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.00 - 3.06 per share. | Indirect | 130,434 | May 22, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.06 - 3.33 per share. | Indirect | 230,326 | May 17, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.09 - 3.11 per share. | Indirect | 566,951 | May 10, 2024 |
| ZUMMO JACQUELINE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| BANDARI JATHIN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| FRY HANNAH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| FABBIO PATRICK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| SHEFFERMAN JESSE M Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| SHEFFERMAN JESSE M Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Jun 27, 2023 |
Related Tickers
LRMR Larimar Therapeutics, Inc.
2.2600
0.00%
ABEO Abeona Therapeutics Inc.
5.21
-0.19%
CGON CG Oncology, Inc.
20.78
+0.24%
MLYS Mineralys Therapeutics, Inc.
13.60
+0.48%
IMUX Immunic, Inc.
1.1400
+3.65%
SLDB Solid Biosciences Inc.
3.6100
+1.40%
LXEO Lexeo Therapeutics, Inc.
3.3800
+0.30%
NKTR Nektar Therapeutics
0.7280
+6.15%
EWTX Edgewise Therapeutics, Inc.
14.95
+0.81%
VTYX Ventyx Biosciences, Inc.
1.1645
+0.39%